| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/27/2000 | DE19845286A1 New carrier material coated with specific antibodies, used to remove tumor necrosis factor and other disease-associated compounds from blood, for treating arthritis or pyelonephritis |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2347172A1 Protein material for slow digestion and its use |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995746A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/26/2000 | EP0995442A1 Use of milk from equines for the manufacture of a preparation for the treatment of bucco-dental troubles |
| 04/26/2000 | EP0995436A2 Ligands for sigma receptors and their therapeutical applications |
| 04/26/2000 | EP0994902A1 Cyclic crf antagonist peptides |
| 04/26/2000 | EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 04/26/2000 | EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994867A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994716A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 04/26/2000 | EP0738269B1 Piperidine derivatives with paf antagonist activity |
| 04/26/2000 | EP0736020B1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 04/26/2000 | EP0683780B1 Imidazopyridines and their use in treating gastrointestinal diseases |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251586A Noval pyrimidine derivatives and process and preparing thereof |
| 04/26/2000 | CN1251307A Chinese medicine for treating stomach disease |
| 04/26/2000 | CN1251306A Process for preparing anti-inflammatory and choleretic granules |
| 04/26/2000 | CN1051714C Patent medicine of traditional Chinese medicine and preparation method |
| 04/26/2000 | CN1051713C Shuangling oral solution of antidiarrheal and production technology thereof |
| 04/26/2000 | CN1051708C Maren soft capsule (Chinese medicine) for treating constipation and preparation method thereof |
| 04/26/2000 | CN1051705C Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use thereof |
| 04/25/2000 | US6054588 Heterocyclic vinyl ethers |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054464 Azabicyclic esters of carbamic acids useful in therapy |
| 04/25/2000 | US6054457 Benzamide derivatives and their use as vasopressin antagonists |
| 04/25/2000 | US6054434 8a-azalides as veterinary antimicrobal agents |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054130 Non-splicing variants of gp350/220 |
| 04/25/2000 | CA2143849C Substituted thiazolidinedione derivatives |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021951A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021931A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021542A1 Methods for stimulating bone formation |
| 04/20/2000 | WO2000021532A1 Methods for inhibiting bone resorption |
| 04/20/2000 | WO2000021523A1 Methods for regulating bone formation |
| 04/20/2000 | WO2000021521A2 Sertraline oral concentrate |
| 04/20/2000 | WO2000021509A2 Methods of treatment |
| 04/20/2000 | WO2000021456A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 04/20/2000 | WO1999065571A3 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/20/2000 | WO1999008691A8 Use of locally delivered metal ions for treatment of periodontal disease |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | DE19845372A1 Verwendung von Katecholderivaten als Proteinaseninhibitoren Using catechol as proteinase inhibitors |
| 04/20/2000 | CA2346943A1 Cyclic tetrapeptide compound and use thereof |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346729A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | CA2346689A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | CA2346038A1 Methods for inhibiting bone resorption |
| 04/20/2000 | CA2346036A1 Methods for regulating bone formation |
| 04/20/2000 | CA2346031A1 Methods for stimulating bone formation |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them |
| 04/19/2000 | EP0993830A2 New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | CN1251105A 2,3-dihydrofuro [3,2-b] pyridin, prepn. and application thereof of therapy |
| 04/19/2000 | CN1251102A Tetrahydropyrido compounds |
| 04/19/2000 | CN1251099A Thiazole benzenesulfonamides as beta 3 agoniste for treatment of diabetes and obesity |
| 04/19/2000 | CN1251038A IL-8 receptor antagonists |
| 04/19/2000 | CN1250780A Shark liver irritant for preventing and curing hepatism and its preparing process |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250665A Medicine for treating constipation and its preparing process |
| 04/19/2000 | CN1250658A Desensitizing chewing gum containing tea extract and is preparing process |
| 04/19/2000 | CN1051560C Method for preparing chelate of antibiotic and complex metallic salt |
| 04/18/2000 | US6051570 Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2000 | US6051220 Composition to improve digestibility and utilization of nutrients |
| 04/18/2000 | US6051219 Method for reducing malodor with Bacillus subtilis Kubota |
| 04/18/2000 | CA1340964C Crf analogs |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 04/13/2000 | WO2000020389A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 04/13/2000 | WO2000020003A1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 04/13/2000 | WO2000019989A2 Use of catechol derivatives as proteinase inhibitors |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |